**Core Concept**
Myasthenia gravis is an autoimmune disease characterized by weakness and rapid fatigue of the muscles under voluntary control. It occurs due to the production of autoantibodies against the acetylcholine receptor (AChR) at the neuromuscular junction, leading to impaired neurotransmission and muscle dysfunction.

**Why the Correct Answer is Right**
The correct answer is closely associated with the pathophysiology of Myasthenia gravis, as it involves the disruption of the acetylcholine receptor. The AChR is a crucial component of the neuromuscular junction, where acetylcholine binds to stimulate muscle contraction. In Myasthenia gravis, autoantibodies against the AChR lead to its downregulation, decreased acetylcholine binding, and ultimately, muscle weakness. This process is mediated by the CD4+ T-cell activation and B-cell proliferation, resulting in the production of autoantibodies.

**Why Each Wrong Option is Incorrect**
* **Option A:** This option is incorrect as it does not directly relate to the pathophysiology of Myasthenia gravis. While muscle weakness is a hallmark symptom, it is not the underlying cause of the disease.
* **Option B:** This option is incorrect as it is a hallmark symptom of Myasthenia gravis, but not closely associated with the underlying pathophysiology.
* **Option D:** This option is incorrect as it is a treatment for Myasthenia gravis, but not closely associated with the disease's pathophysiology.

**Clinical Pearl / High-Yield Fact**
A key clinical correlation to remember is that Myasthenia gravis often coexists with other autoimmune diseases, such as rheumatoid arthritis, lupus, or thymoma. Therefore, a thorough medical history and physical examination are essential to identify these associated conditions.

**Correct Answer: B. Muscle weakness**